Ora Pharm buys key Helius Therapeutics assets in major NZ deal by Adam Sheldon May 13, 2026May 13, 2026 Ora Pharm has signed a binding conditional agreement to acquire the key assets of collapsed firm […]
Cash shortage offers only ‘limited window’ to sell Helius, administrator tells creditors by Steve Jones March 18, 2026March 18, 2026
Helius Therapeutics enters voluntary administration, shuts Auckland manufacturing facility by Steve Jones March 11, 2026March 11, 2026
NZMCC urges Dispensed to ‘rethink’ kiosk model across the Tasman by Steve Jones March 6, 2025March 6, 2025
NZ Drug Foundation publishes medicinal cannabis guide for employers and workers by Martin Lane February 20, 2025February 20, 2025
Ora Pharm launches plant processing and export services, inks deal with Breathe Life Sciences by Martin Lane July 2, 2024November 25, 2024
‘Desperately needed’ export reforms back on agenda in New Zealand by Steve Jones April 23, 2024April 24, 2024
New Zealand reclassifies low-dose CBD, paving the way for OTC sales by Martin Lane October 17, 2023April 30, 2024
Blow for NZ industry as over-the-counter CBD is knocked back by Steve Jones December 5, 2022December 6, 2022
